News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,120 Results
Type
Article (39154)
Company Profile (283)
Press Release (648683)
Section
Business (203904)
Career Advice (1996)
Deals (35373)
Drug Delivery (89)
Drug Development (80855)
Employer Resources (168)
FDA (16099)
Job Trends (14808)
News (344649)
Policy (32450)
Tag
Academia (2530)
Alliances (49188)
Alzheimer's disease (1263)
Approvals (16066)
Artificial intelligence (146)
Bankruptcy (353)
Best Places to Work (11582)
Biotechnology (200)
Breast cancer (190)
Cancer (1381)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (284)
Clinical research (64722)
Collaboration (486)
Compensation (264)
COVID-19 (2542)
C-suite (109)
Data (1396)
Diabetes (177)
Diagnostics (6171)
Earnings (84898)
Employer resources (146)
Events (110027)
Executive appointments (400)
FDA (16795)
Funding (437)
Gene therapy (197)
GLP-1 (599)
Government (4333)
Healthcare (18697)
Infectious disease (2635)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16352)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7864)
Lung cancer (200)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19201)
Metabolic disorders (461)
Neuroscience (1587)
NextGen Class of 2024 (6501)
Non-profit (4467)
Northern California (1709)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (122)
People (56468)
Phase I (20135)
Phase II (28502)
Phase III (21245)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5891)
Regulatory (21690)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1474)
Startups (3562)
United States (15303)
Vaccines (564)
Weight loss (182)
Date
Today (34)
Last 7 days (98)
Last 30 days (2074)
Last 365 days (35224)
2024 (35224)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (196)
Asia (37288)
Australia (6089)
California (3851)
Canada (1461)
China (314)
Colorado (173)
Connecticut (179)
Europe (79849)
Florida (539)
Georgia (136)
Illinois (387)
Indiana (227)
Maryland (638)
Massachusetts (2982)
Michigan (175)
Minnesota (294)
New Jersey (1113)
New York (1098)
North Carolina (744)
Northern California (1709)
Ohio (146)
Pennsylvania (932)
South America (1092)
Southern California (1474)
Texas (556)
Utah (108)
Washington State (401)
688,120 Results for "advaxis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Advaxis and Ayala Pharmaceuticals Complete Merger
Advaxis, Inc. (OTCQX: ADXS) today announced the completion of a previously announced merger with Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA).
January 19, 2023
·
4 min read
Deals
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
Ayala Pharmaceuticals, Inc. and Advaxis, Inc. announced that they have entered into a definitive merger agreement.
October 19, 2022
·
13 min read
Deals
Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement
Ayala Pharmaceuticals, Inc. and Advaxis, Inc. announced that they have entered into a definitive merger agreement.
October 19, 2022
·
13 min read
Pharm Country
Advaxis, Inc. Announces 1-for-80 Reverse Stock Split
Advaxis, Inc. announced that it has filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company to implement a one-for-80 reverse split of its issued and outstanding common stock.
June 3, 2022
·
5 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Drug Development
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
Advaxis, Inc. today announced an update on the Phase 1 clinical study evaluating ADXS-504, the company’s off-the-shelf neoantigen drug candidate, in patients with biochemically recurrent (early) prostate cancer that is being conducted at Columbia University Irving Medical Center.
January 12, 2023
·
5 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Pharm Country
Advaxis, Inc. Issues Letter to Stockholders - Nov 19, 2021
Advaxis, Inc., a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, issued the following statement to stockholders.
November 19, 2021
·
10 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Deals
OTC Markets Group Welcomes Advaxis, Inc. to OTCQX
OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company, has qualified to trade on the OTCQX® Best Market.
December 23, 2021
·
2 min read
1 of 68,812
Next
